# A Phase II Study of UCN-01 in Metastatic Melanoma

> **NCT00072189** · PHASE2 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 17 (actual)

## Conditions studied

- Recurrent Melanoma
- Stage IV Melanoma

## Interventions

- **DRUG:** 7-hydroxystaurosporine
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00072189
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Early termination for discouraging results
- **Last updated:** 2015-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00072189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00072189, "A Phase II Study of UCN-01 in Metastatic Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00072189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*